NASDAQ:BOLT
Bolt Biotherapeutics
- Stock
Last Close
0.83
17/05 20:00
Market Cap
40.62M
Beta: 0.99
Volume Today
578.24K
Avg: 250.78K
PE Ratio
−0.60
PFCF: −0.56
Dec '19 | Mar '20 | Jun '20 | Sep '20 | Dec '20 | Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.00 - | 0.00 - | 0.00 26.78% | 0.00 74.15% | 0.01 86.19% | 0.01 60.71% | 0.01 28.00% | 0.01 42.99% | 0.01 15.15% | 0.01 91.85% | 0.01 9.31% | 0.04 182.31% | |||||||
cash conversion cycle | -1.16K - | -420.69 - | |||||||||||||||||
cash per share | 2.49 - | 2.70 - | 0.72 73.42% | 12.40 1,629.72% | 6.69 46.03% | 5.72 14.53% | 5.00 12.68% | 5.14 2.91% | 4.73 8.04% | 4.57 3.37% | 4.50 1.57% | 3.35 25.43% | 3.33 0.58% | 3.17 5.02% | 0.00 99.91% | 2.40 88,995.34% | |||
company equity multiplier | -1.06 - | -0.83 - | -0.44 46.42% | 1.07 341.39% | 1.17 9.57% | 1.21 3.44% | 1.23 1.40% | 1.24 0.64% | 1.25 1.06% | 1.30 4.11% | 1.33 1.96% | 1.31 1.56% | 1.34 2.61% | 1.37 1.90% | 1.42 3.66% | 1.37 3.20% | |||
days of inventory outstanding | -545.45 - | ||||||||||||||||||
days of payables outstanding | 717.27 - | 436.05 - | |||||||||||||||||
days of sales outstanding | 99.68 - | 15.36 - | |||||||||||||||||
dividend yield | |||||||||||||||||||
ebit per revenue | -146.26 - | -53.32 63.54% | -165.82 210.97% | -31.28 - | -53.30 70.36% | -29.37 44.90% | -16.55 43.63% | -10.58 36.08% | -14.91 40.93% | -10.08 32.37% | -13.84 37.23% | -7.19 48.03% | -9.46 31.55% | -3.24 65.75% | |||||
ebt per ebit | 0.98 - | 0.99 0.25% | 1.00 0.83% | 0.81 19.01% | 1.83 127.49% | 1.33 27.64% | 0.99 25.21% | 0.99 0.19% | 1.00 0.86% | 0.99 1.13% | 0.98 0.89% | 0.97 0.93% | 0.95 2.39% | 0.92 2.98% | 0.91 1.26% | 0.89 1.80% | 0.91 1.31% | 0.63 30.17% | |
effective tax rate | 0.24 - | -0.45 286.22% | -0.25 44.93% | 0.01 - | 0.01 37.09% | 0.02 108.42% | 0.03 54.79% | 0.05 93.34% | 0.08 62.03% | 0.03 - | |||||||||
enterprise value multiple | -45.18 - | -30.33 - | -367.97 1,113.16% | -51.59 85.98% | -22.67 56.05% | -20.32 10.37% | -6.63 67.36% | -3.45 48.03% | -3.37 2.22% | -3.11 7.84% | -2.96 4.86% | -3.32 12.35% | -2.91 12.42% | -2.81 3.52% | -2.15K 76,542.04% | -4.35 99.80% | |||
fixed asset turnover | 0.01 - | 0.02 - | 0.02 31.86% | 0.03 63.74% | 0.05 75.92% | 0.07 48.81% | 0.05 30.48% | 0.07 34.78% | 0.05 18.06% | 0.10 84.04% | 0.09 13.70% | 0.23 166.07% | |||||||
free cash flow per share | -0.45 - | -0.72 58.18% | -0.94 30.91% | -0.98 4.28% | -0.43 55.68% | -0.77 78.53% | -0.13 83.42% | -0.53 314.11% | -0.49 7.18% | -0.67 36.27% | -0.57 15.24% | -0.38 33.42% | -0.48 27.51% | -0.62 28.58% | -0.40 35.40% | -0.45 11.52% | -0.44 - | ||
gross profit margin | 1 - | 1 0% | 1 0% | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.82 18.28% | 1 22.36% | 0.91 8.68% | |||||
interest coverage | -330.18 - | -120.59 63.48% | -58.38 51.59% | -38.07 34.79% | 20.17 152.99% | 12.83 36.39% | |||||||||||||
inventory turnover | -0.17 - | ||||||||||||||||||
long term debt to capitalization | -0.18 - | -0.15 - | -0.10 34.13% | 0.03 129.56% | 0.07 150.33% | 0.08 4.30% | 0.08 6.13% | 0.09 6.22% | 0.09 6.29% | 0.10 9.84% | 0.11 5.83% | 0.11 4.68% | 0.12 6.27% | 0.12 5.81% | 0.13 7.91% | 0.14 3.05% | |||
net income per ebt | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.99 0.84% | 0.98 0.91% | 0.97 0.97% | 0.95 2.59% | 0.92 3.41% | 1 9.23% | 1 0% | 1 0% | 1 0% | |
net profit margin | -144.03 - | -52.64 63.45% | -165.06 213.56% | -31.11 - | -53.46 71.84% | -28.88 45.98% | -15.99 44.65% | -10.02 37.29% | -13.43 34.00% | -8.51 36.63% | -12.60 48.02% | -6.43 48.97% | -8.57 33.27% | -2.05 76.08% | |||||
operating cash flow per share | -0.45 - | -0.69 53.91% | -0.88 27.26% | -0.89 2.04% | -0.40 54.75% | -0.77 90.30% | -0.11 85.86% | -0.50 362.10% | -0.48 5.14% | -0.65 37.16% | -0.56 14.89% | -0.36 35.57% | -0.48 33.11% | -0.62 29.89% | -0.40 35.53% | -0.44 10.67% | -0.44 - | ||
operating cycle | -445.77 - | 15.36 - | |||||||||||||||||
operating profit margin | -146.26 - | -53.32 63.54% | -165.82 210.97% | -31.28 - | -53.30 70.36% | -29.37 44.90% | -16.55 43.63% | -10.58 36.08% | -14.91 40.93% | -10.08 32.37% | -13.84 37.23% | -7.19 48.03% | -9.46 31.55% | -3.24 65.75% | |||||
payables turnover | 0.13 - | 0.21 - | |||||||||||||||||
pretax profit margin | -144.03 - | -52.64 63.45% | -165.06 213.56% | -31.11 - | -53.46 71.84% | -29.12 45.52% | -16.27 44.14% | -10.30 36.68% | -14.17 37.56% | -9.30 34.39% | -12.60 35.51% | -6.43 48.97% | -8.57 33.27% | -2.05 76.08% | |||||
price fair value | -9.81 - | -6.03 - | -9.76 61.78% | 2.33 123.91% | 1.91 18.05% | 1.71 10.46% | 0.73 57.35% | 0.45 39.00% | 0.37 17.87% | 0.29 19.59% | 0.28 3.23% | 0.33 16.70% | 0.34 2.34% | 0.31 9.83% | 376.92 122,851.32% | 0.55 99.85% | |||
receivables turnover | 0.90 - | 5.86 - | |||||||||||||||||
return on assets | -0.19 - | -0.16 - | -0.67 311.63% | -0.08 88.70% | -0.07 9.79% | -0.07 3.22% | -0.09 25.82% | -0.08 5.92% | -0.09 3.06% | -0.09 0.78% | -0.08 3.52% | -0.08 9.38% | -0.09 25.59% | -0.09 2.09% | -0.11 20.86% | -0.08 32.47% | |||
return on capital employed | -0.24 - | -0.24 - | -0.48 100.42% | -0.06 87.71% | -0.07 22.97% | -0.08 4.75% | -0.09 24.51% | -0.09 4.15% | -0.10 5.32% | -0.10 5.79% | -0.10 1.81% | -0.10 5.67% | -0.11 18.18% | -0.12 1.33% | -0.14 22.18% | -0.14 4.51% | |||
return on equity | 0.20 - | 0.13 - | 0.30 120.54% | -0.08 127.27% | -0.08 1.16% | -0.09 6.77% | -0.11 27.59% | -0.10 5.32% | -0.11 4.16% | -0.11 4.92% | -0.11 1.63% | -0.10 10.80% | -0.13 28.87% | -0.13 0.23% | -0.16 25.28% | -0.10 34.64% | |||
total debt to capitalization | -0.29 - | -0.17 - | -0.12 33.27% | 0.03 129.43% | 0.08 132.99% | 0.08 4.86% | 0.09 6.72% | 0.09 4.62% | 0.10 6.82% | 0.11 10.71% | 0.12 6.10% | 0.12 5.33% | 0.13 6.97% | 0.14 6.57% | 0.15 8.72% | 0.16 4.00% |
All numbers in USD (except ratios and percentages)